Covista Inc. (CVSA)
NYSE · Consumer Defensive · Education & Training Services
$125.39−0.07%as of Oct 6, 2026, 1:35 AM ET
- Market cap
- $4.3B
- P/E (trailing)
- 16.7
- Forward P/E
- 12.5
- 52-week range
- $86.97 – $156.26
- 52-week change
- −16.27%
- EPS (trailing)
- $7.49
- Analyst rating
- 1.8 Buy
- Next earnings
- Oct 29, 2026
Fiscal year to Jun 2026
- Revenue
- $2.0B (+9.27%)
- Net income
- $252M
- Operating margin
- 19.6%
- Diluted EPS
- $7.04
- Free cash flow
- $393M
From the company’s annual report on SEC EDGAR.
About Covista Inc.
Covista Inc., together with its subsidiaries, provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. It operates in three segments: Chamberlain, Walden, and Medical and Veterinary. The company provides degree programs, including bachelor's, master's, and doctoral degrees; and online certificate programs for nursing, health professions, medical, and veterinary postsecondary education, counseling, business, information technology, psychology, public health, social work and human services, public administration and public policy, and criminal justice. It also operates Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. The company was formerly known as Adtalem Global Education Inc. and changed its name to Covista Inc. in February 2026. Covista Inc. was incorporated in 1987 and is headquartered in Chicago, Illinois.
Headquarters: Chicago, United States · 4,736 employees · covista.com